Relationship between long-acting reversible contraception and acne in a cohort of adolescents and young adults

被引:1
作者
Boos, Markus D. [1 ,2 ,8 ]
Ryan, Morgan E. [3 ]
Milliren, Carly [3 ]
Golub, Sarah [4 ]
Maslyanskaya, Sofya [5 ]
Escovedo, Michelle [6 ]
Divasta, Amy [7 ]
Pitts, Sarah [7 ]
机构
[1] Univ Washington, Sch Med, Dept Pediat, Div Dermatol, Seattle, WA USA
[2] Seattle Childrens Hosp, Seattle, WA USA
[3] Boston Childrens Hosp, Inst Ctr Clin & Translat Res, Boston, MA USA
[4] Univ Washington, Seattle Childrens Hosp, Sch Med, Dept Pediat, Seattle, WA USA
[5] Childrens Hosp Montefiore, Div Adolescent Med, New York, NY USA
[6] Childrens Hosp Los Angeles, Div Adolescent Young Adult Med, Los Angeles, CA USA
[7] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA
[8] Seattle Childrens Hosp, Dept Surg, 4800 Sand Point Way NE,OC9 833, Seattle, WA 98105 USA
关键词
acne; adolescence; long-acting reversible contraception; progestin;
D O I
10.1111/pde.15578
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundThe use of progestin-only long-acting reversible contraception (LARC) may be a risk factor for acne. Few studies have focused primarily on the effects of hormonal LARC on the development or exacerbation of acne in adolescents and young adults. We sought to understand the incidence and management of acne following hormonal LARC insertion in this adolescent/young adult population.MethodsA secondary data analysis was conducted of prospectively collected quality improvement (QI) data from the Adolescent Medicine LARC Collaborative. Subjects were evaluated by clinicians in adolescent medicine clinics at participating study sites, and acne severity was documented using a standardized recording instrument and scale. Descriptive statistics were reported as frequencies and percentages for categorical variables or mean and standard deviation (SD) for continuous variables. We compared demographic and clinical characteristics by those who had worsening acne, accounting for site inter-correlation using Cochran-Mantel-Haenszel chi-square tests for categorical variables and linear generalized estimating equation (GEE) regression for continuous variables.ResultsOf 1319 subjects who completed LARC insertion, 28.5% (376/1319) experienced worsening acne following use of progestin-only LARC. Acne was a contributing factor to LARC removal in only 3% (40/1319), and the sole reason for removal in 0.4% (5/1319) of all subjects. As this was a secondary analysis of prospectively collected QI data, limitations of this study include incomplete or inaccurate documentation of acne severity. Moreover, LARC insertions without follow-up/removal visits or with only follow-up/removal within 8 weeks of insertion were excluded from our study, which may also bias results.ConclusionsAdolescents and young adults seeking progestin-only LARC should be counseled about the potential for developing acne or experiencing a worsening of existing acne during LARC use. However, acne was not a common reason for LARC discontinuation.
引用
收藏
页码:628 / 634
页数:7
相关论文
共 50 条
  • [31] Advanced Practice Registered Nurses and Long-Acting Reversible Contraception
    Kelly, Patricia J.
    Cheng, An-Lin
    Carlson, Kimberly
    Witt, Jacki
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2017, 62 (02) : 190 - 195
  • [32] Source of care and variation in long-acting reversible contraception use
    Groskaufmanis, Lauren
    Masho, Saba W.
    FERTILITY AND STERILITY, 2016, 105 (02) : 401 - 409
  • [33] Changes in the use of effective and long-acting reversible contraception in Vietnam
    Asad, Sarah
    Hebert, Courtney
    Andridge, Rebecca
    Nghia Nguyen
    Gallo, Maria F.
    CONTRACEPTION, 2019, 99 (03) : 165 - 169
  • [34] Knowledge and Attitudes About Sterilization and Long-Acting Reversible Contraception
    Leung, Andrea
    Loh, Andrew
    Pentlicky, Sara
    Gurney, Elizabeth P.
    MATERNAL AND CHILD HEALTH JOURNAL, 2021, 25 (08) : 1336 - 1344
  • [35] Factors associated with postpartum use of long-acting reversible contraception
    Oduyebo, Titilope
    Zapata, Lauren B.
    Boutot, Maegan E.
    Tepper, Naomi K.
    Curtis, Kathryn M.
    D'Angelo, Denise V.
    Marchbanks, Polly A.
    Whiteman, Maura K.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (01) : 43.e1 - 43.e11
  • [36] Prevention of Unintended Pregnancy A Focus on Long-Acting Reversible Contraception
    Pickle, Sarah
    Wu, Justine
    Burbank-Schmitt, Edith
    PRIMARY CARE, 2014, 41 (02): : 239 - +
  • [37] Interdependent Barriers to Providing Adolescents with Long-Acting Reversible Contraception: Qualitative Insights from Providers
    Murphy, Molly K.
    Stoffel, Cindy
    Nolan, Meghan
    Haider, Sadia
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2016, 29 (05) : 436 - 442
  • [38] Impact of long-acting reversible contraception on return for repeat abortion
    Rose, Sally B.
    Lawton, Beverley A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (01) : 37.e1 - 37.e6
  • [39] Familiarity and acceptability of long-acting reversible contraception and contraceptive choice
    Paul, Rachel
    Huysman, Bridget C.
    Maddipati, Ragini
    Madden, Tessa
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (04) : S884.e1 - S884.e9
  • [40] Recent progress in advanced biomaterials for long-acting reversible contraception
    Mingzhe Yan
    Yanming Zhang
    Zhihang Wu
    Yifei Li
    Keke Dou
    Banghui Wang
    Yingruo Wang
    Qihui Zhou
    Journal of Nanobiotechnology, 20